Synonyms: BMY-13805 | BMY13805 | Exxua® | MJ-13805 | MJ13805 | ORG-13011 | Travivo (gepirone extended-release)
gepirone is an approved drug (FDA (2023))
Compound class:
Synthetic organic
Comment: Gepirone (BMY-13805) is a 5-HT1A receptor agonist [5].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2023)) |
IUPAC Name |
4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione |
International Nonproprietary Names | |
INN number | INN |
5676 | gepirone |
Synonyms |
BMY-13805 | BMY13805 | Exxua® | MJ-13805 | MJ13805 | ORG-13011 | Travivo (gepirone extended-release) |
Database Links | |
BindingDB Ligand | 50005132 |
ChEBI | CHEBI:135990 |
ChEMBL Ligand | CHEMBL284092 |
DrugBank Ligand | DB12184 |
GtoPdb PubChem SID | 485206051 |
PubChem CID | 55191 |
Search Google for chemical match using the InChIKey | QOIGKGMMAGJZNZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | QOIGKGMMAGJZNZ |
Search PubMed clinical trials | gepirone |
Search PubMed titles | gepirone |
Search PubMed titles/abstracts | gepirone |
UniChem Compound Search for chemical match using the InChIKey | QOIGKGMMAGJZNZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | QOIGKGMMAGJZNZ-UHFFFAOYSA-N |